IMPROVED SURVIVAL IN PATIENTS WITH DIASTOLIC HEART FAILURE DISCHARGED ON BETA-BLOCKER AND ACE INHIBITORS

Kevin Shah,Niraj Parekh,Paul Clopton,Inderjit Anand,Robert Christenson,Lori B. Daniels,Salvatore Di Somma,Geros Filippatos,James McCord,Christian Mueller,Sean-Xavier Neath,Richard M. Nowak,W. Frank Peacock,Piotr Ponikowski,Stefan Anker,Alan S. Maisel

IMPROVED SURVIVAL IN PATIENTS WITH DIASTOLIC HEART FAILURE DISCHARGED ON BETA-BLOCKER AND ACE INHIBITORS

2013

Kevin Shah
Niraj Parekh
Paul Clopton
Inderjit Anand
Robert Christenson
Lori B. Daniels
Salvatore Di Somma
Geros Filippatos
James McCord
Christian Mueller
Sean-Xavier Neath
Richard M. Nowak
W. Frank Peacock
Piotr Ponikowski
Stefan Anker
Alan S. Maisel

Medical management of heart failure with preserved ejection fraction (HFPEF) remains unclear. This analysis was to assess the benefit of ACE-inhibitors (ACEi) and beta blockers (BB) in patients with HFPEF and in heart failure with reduced ejection fraction (HFREF). The BACH (Biomarkers in Acute

Keywords:

Beta blocker
Diabetes mellitus
Cardiology
Diastolic heart failure
Medicine
Internal medicine
Heart failure
Management of heart failure
Beta (finance)
Ejection fraction
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations